Arjan Boltjes

" Instead, #Hepatoblastoma #tumors contain a large suppressive #myeloid compartment which poses opportunities for targeting. Specifically, therapeutic antibodies
targeting the tumor antigen #GPC3 to induce ADCP by #macrophages, in combination with myeloid
#ImmuneCheckpointBlockade (#CD47/SIRPa, or VISTA) could be a feasible strategy to explore in future studies"

Krijgsman et al. from Vercoulen lab in the #UMCUtrecht, on #bioRXiv:
biorxiv.org/content/10.1101/20

#scRNAseq #spatial #CyTOF #immunology

Hepatoblastoma exhibits a predominantly myeloid immune landscape and reveals opportunities for macrophage targeted immunotherapy

Background & Aims Hepatoblastoma (HB) is a rare form…

www.biorxiv.org
Claire McCarthy

Check out some #CoolScienceImages from a Nature Communications study on #fluorescencefriday. Nikolos et al. showed that an iDAMP blockade approach synergizes with #chemotherapy and sensitizes #bladdercancer to #immunotherapy in #preclinicalmodels.

nature.com/articles/s41467-022

Music: Baby Don’t Hurt Me by David Guerra, Anne-Marie, & Coi Leray

#CancerMoonshot
#CancerMoonshotSeminar
#CMSSChan
#cancerresearch
#ImmuneCheckpointBlockade

Judit Svensson Arvelund

Cool paper dissecting the mechanism of action of #immunecheckpointblockade, anti-CTLA-4, and showing the important role of #myeloidcells #macrophages

"Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling"

nature.com/articles/s43018-022

Hao Yin

#Senescence #ImmuneSurveillance
Next-gen #Senolytic

#ImmuneCheckpointBlockade activates CD8+ T cytotoxicity against (inflammed🔥) PD-L1+ senescent cells->
⏬adverse phenotypes in🐭#Aging+#NASH

Dr. Yoshikazu Johmura & Makoto Nakanishi labs Nature 2022
nature.com/articles/s41586-022